Mayo: Supreme Court case is about how far patents can go
Mayo Clinic is not asking the US Supreme Court for an “exotic” application of Section 101, and the personalised medicine industry will be fine without patents like that owned by Prometheus, the company’s counsel told Managing IP on Thursday
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article: